Impaired Olfactory Could Be Early Indicator of Parkinson's

How do you know if Alzheimer's or Parkinson's are going to attack you or someone you love, when the tests done by doctors are notoriously inaccurate?

An impaired sense of smell could be an early indicator of Parkinson's disease, occurring up to four years before motor skill problems appear.

The study, published in the February issue of the Annals of Neurology, followed 2,267 men who received olfactory testing at the Kuakini Medical Center in Honolulu at least once during two periods in the 1990s.

They were followed for up to eight years and during that time, 35 of the men developed the disease. An odor identification problem preceded the development of Parkinson's by at least four years in these men.

Decreased odor identification was associated with older age, smoking, more coffee consumption, less frequent bowel movements, lower cognitive function and excessive daytime sleepiness. Even after adjusting for these factors, those with the lowest odor identification scores had a five times greater risk of developing Parkinson's than those with the highest scores.

The results strengthen findings from earlier studies that suggest olfactory impairment begins between two and seven years before diagnosis.

Losing Sense of Smell Not Well Understood

Why problems with smelling accompany Parkinson's is not completely understood; however, nerve loss and the formation of Lewy bodies - abnormal clumps of proteins inside nerve cells that are thought to be a marker of the disease - are known to take place in the olfactory structures of patients with the disease.

One previous study involving brain dissection of deceased patients with neurological disease found that olfactory structures are the earliest brain regions affected by Lewy degeneration, which supports the idea that an impaired sense of smell could be one of the earliest signs of Parkinson's disease.

An impaired sense of smell could also be caused by impaired sniffing, which may be another motor symptom of Parkinson's, dementia and early-onset Alzheimer's.

Olfactory testing, along with screening for other potential early indicators of Parkinson's disease, such as constipation or sleep disturbances, could provide a simple and relatively economic means of identifying individuals at high risk who could participate in trials of medications designed to prevent or slow disease progression .

The National Institute of Neurological Disorders and Stroke has more about Parkinson's disease.

Further Tips & Suggestions:

• The human brain consists of nearly 60 percent fat. Essential fatty acids (EFA) are not made by the body and obtained from our food and must be replenished daily. Omega-3 fatty acids in particular are the building blocks of cell membranes that promote new brain cell formation. Omega-3s also support neurotransmitter receptors, facilitating how information is communicated in the brain. I recommend obtaining EFA from plants, especially flax, hemp, chia or pumpkin seeds. Or try our Omega 3-6-9 formula from flax, evening primrose, canola, black current and pumpkin oils.
• Our Mind Power formula contains special brain anti-aging nutrients to fight free radical damage to brain tissue. This formula is highly recommended for anyone who is involved with "volume thinking" and wanting to keep their brain sharp, as well as individuals with memory or learning difficulties, autism, attention disorders.